1. Home
  2. VINP vs ZVRA Comparison

VINP vs ZVRA Comparison

Compare VINP & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vinci Partners Investments Ltd.

VINP

Vinci Partners Investments Ltd.

HOLD

Current Price

$9.84

Market Cap

638.8M

Sector

Finance

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$13.76

Market Cap

741.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VINP
ZVRA
Founded
2009
2006
Country
Brazil
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
638.8M
741.9M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
VINP
ZVRA
Price
$9.84
$13.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$14.00
$23.00
AVG Volume (30 Days)
63.3K
1.8M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
5.72%
N/A
EPS Growth
N/A
159.21
EPS
N/A
0.60
Revenue
N/A
$106,470,000.00
Revenue This Year
$18.07
$37.27
Revenue Next Year
$12.74
$53.42
P/E Ratio
$24.41
$23.90
Revenue Growth
N/A
350.91
52 Week Low
$9.20
$7.16
52 Week High
$13.61
$14.58

Technical Indicators

Market Signals
Indicator
VINP
ZVRA
Relative Strength Index (RSI) 47.73 65.65
Support Level $9.66 $8.26
Resistance Level $10.88 $14.27
Average True Range (ATR) 0.38 0.61
MACD 0.03 0.09
Stochastic Oscillator 30.66 73.75

Price Performance

Historical Comparison
VINP
ZVRA

About VINP Vinci Partners Investments Ltd.

Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: